It is best not to invest in so-called index funds, especially the Shanghai and Shenzhen 300 Index. There are also many good things about fixed investment index funds on the Internet, all of which are theories from European and American markets.
Index funds have two distinct characteristics: first, passive investment; The second is to continue high-level operation. The characteristics of index funds determine that they will have different performances in different market environments and different inspection stages. Generally speaking, the investment value of index funds is very prominent in bull market and staged rebound, but in bear market and wide fluctuation market, index funds have no investable value. At present, the economy is in a weak recovery, funds are in a neutral and tight pattern, and the market is dominated by structural opportunities, so it is difficult for index funds to have sustained performance opportunities.
Therefore, according to the characteristics of China A-share market, it is difficult for index funds to make great achievements.
Instead, we should choose a fund that a good company actively manages.
Industrial funds mainly invest in specific industries, while pharmaceutical funds make 8% of assets into shares of pharmaceutical companies. The advantage lies in centralization, and the disadvantage lies in centralization. It belongs to a typical high-risk and high-return category. The ability to select stocks for fund managers is also relatively high. This kind of fund is relatively suitable for fixed investment, and some market risks are leveled through long-term fixed investment. One-time purchase requires investors' risk tolerance.
In the early stage, influenced by the state's investigation and punishment of commercial bribery of pharmaceutical enterprises, the pharmaceutical sector showed a certain degree of correction. At present, it is in the consolidation stage and can be involved for a long time. However, due to the large increase in pharmaceutical funds last year, it is best to insist on fixed investment for more than 5 years, otherwise there may be small losses in the short term.
The aging society in China will become more and more serious, and the huge demand is enough to support the performance of pharmaceutical companies. Moreover, medicine is an aperiodic industry with anti-inflation properties. There is no problem in the medium and long-term prospects of the industry. Appropriate participation is recommended. You can pay attention to Huitianfu Medical Fund and Yifangda Medical Fund.
Electronic science and technology funds include: Changsheng Electronics, Guo Fu Hi-Tech, HSBC Jintrust Science and Technology, etc. Some time ago, there was a sharp rise. However, the competition of electronic listed companies will be fierce, and they need to innovate constantly. Therefore, there are more unknown factors than pharmaceutical funds, and the risk is slightly greater than that of pharmaceutical funds, which is also an option for long-term fixed investment.